# Annovis Bio, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 17:10 ET
- Period: 2024-06-12
- Accession: 0001104659-24-054167
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924054167/tm243000d1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465924054167/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465924054167/tm243000d1_def14a.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-054167. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
